{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:28:05Z","timestamp":1773296885746,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T00:00:00Z","timestamp":1536105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Boehringer Ingelheim"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.rmed.2018.08.014","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T16:13:34Z","timestamp":1535559214000},"page":"82-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Tiotropium add-on to inhaled corticosteroids versus addition of long-acting \u03b22-agonists for adults with asthma"],"prefix":"10.1016","volume":"143","author":[{"given":"Roland","family":"Buhl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Mark","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2591-4696","authenticated-orcid":false,"given":"William W.","family":"Busse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2018.08.014_bib1","series-title":"Asthma. Fact sheet 307","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.rmed.2018.08.014_bib2","series-title":"GINA Report: Global Strategy for Asthma Management and Prevention","author":"Global Initiative for Asthma","year":"2018"},{"key":"10.1016\/j.rmed.2018.08.014_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1183\/09059180.00008111","article-title":"Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years","volume":"21","author":"Demoly","year":"2012","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2018.08.014_bib4","first-page":"1","article-title":"Asthma control and disease burden in patients with asthma and allergic comorbidities","author":"Lee","year":"2017","journal-title":"J. Asthma"},{"key":"10.1016\/j.rmed.2018.08.014_bib5","doi-asserted-by":"crossref","first-page":"14009","DOI":"10.1038\/npjpcrm.2014.9","article-title":"Asthma control and management in 8,000 European patients: the REcognise asthma and LInk to symptoms and experience (REALISE) survey","volume":"24","author":"Price","year":"2014","journal-title":"NPJ Prim. Care Respir. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib6","first-page":"CD011438","article-title":"Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta 2-agonists (LABA) for adults with asthma","volume":"6","author":"Kew","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2018.08.014_bib7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(15)00031-4","article-title":"Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials","volume":"3","author":"Kerstjens","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib8","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.2015.13277","article-title":"Anticholinergic vs long-acting beta-agonist in combination with inhaled corticosteroids in black adults with asthma: the BELT randomized clinical trial","volume":"314","author":"Wechsler","year":"2015","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.rmed.2018.08.014_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2011.06.004","article-title":"Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg\/Arg patients with asthma","volume":"128","author":"Bateman","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2018.08.014_bib10","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib11","first-page":"944","article-title":"Therapeutic effects of a long-acting cholinergic receptor blocker, tiotropium bromide, on asthma","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res."},{"key":"10.1016\/j.rmed.2018.08.014_bib12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archinte.159.9.941","article-title":"Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis","volume":"159","author":"Lipworth","year":"1999","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0091-6749(98)70353-7","article-title":"Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma","volume":"101","author":"Busse","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2018.08.014_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.323.7307.253","article-title":"Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis","volume":"323","author":"Holt","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.rmed.2018.08.014_bib15","first-page":"CD005535","article-title":"Addition of long-acting beta 2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children","volume":"5","author":"Ducharme","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2018.08.014_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.rmed.2017.04.008","article-title":"Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators","volume":"128","author":"Halpin","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MCP.0000000000000344","article-title":"Anticholinergic drugs in asthma therapy","volume":"23","author":"D'Amato","year":"2016","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1378\/chest.14-1698","article-title":"What is the role of tiotropium in asthma?: a systematic review with meta-analysis","volume":"147","author":"Rodrigo","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2018.08.014_bib19","series-title":"Spiriva Respimat 2.5 microgram, Inhalation Solution - Summary of Product Characteristics","author":"Boehringer Ingelheim Limited","year":"2016"},{"key":"10.1016\/j.rmed.2018.08.014_bib20","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/ph3030514","article-title":"Inhaled corticosteroids","volume":"3","author":"Barnes","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.rmed.2018.08.014_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1124\/jpet.109.152470","article-title":"Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs","volume":"330","author":"Casarosa","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.rmed.2018.08.014_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/17476348.2017.1289844","article-title":"Role of muscarinic antagonists in asthma therapy","volume":"11","author":"Cazzola","year":"2017","journal-title":"Expet Rev. Respir. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tips.2014.11.005","article-title":"Acetylcholine beyond bronchoconstriction: roles in inflammation and remodeling","volume":"36","author":"Kistemaker","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.rmed.2018.08.014_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pupt.2017.06.010","article-title":"The effect of tiotropium in combination with olodaterol on house dust mite-induced allergic airway disease","volume":"45","author":"John-Schuster","year":"2017","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2018.08.014_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2500\/aap.2016.37.3991","article-title":"Effects of the addition of tiotropium on airway dimensions in symptomatic asthma","volume":"37","author":"Hoshino","year":"2016","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.rmed.2018.08.014_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pupt.2009.06.002","article-title":"Alternative mechanisms for tiotropium","volume":"22","author":"Bateman","year":"2009","journal-title":"Pulm. Pharmacol. Therapeut."},{"key":"10.1016\/j.rmed.2018.08.014_bib27","first-page":"CD005533","article-title":"Addition of long-acting beta 2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma","volume":"4","author":"Ducharme","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2018.08.014_bib28","first-page":"CD001281","article-title":"Long-acting beta 2-agonists versus theophylline for maintenance treatment of asthma","volume":"3","author":"Tee","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2018.08.014_bib29","first-page":"CD003137","article-title":"Addition to inhaled corticosteroids of long-acting beta 2-agonists versus anti-leukotrienes for chronic asthma","volume":"1","author":"Chauhan","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2018.08.014_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaip.2015.08.017","article-title":"The effect of tiotropium in symptomatic asthma despite low- to medium-dose inhaled corticosteroids: a randomized controlled trial","volume":"4","author":"Paggiaro","year":"2016","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2018.08.014_bib31","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib32","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaci.2013.08.003","article-title":"Predictors of response to tiotropium versus salmeterol in asthmatic adults","volume":"132","author":"Peters","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2018.08.014_bib33","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1183\/09031936.96.09081684","article-title":"Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action","volume":"9","author":"van Noord","year":"1996","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2018.08.014_bib34","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1378\/chest.126.6.1946","article-title":"Tiotropium bromide","volume":"126","author":"Gross","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2018.08.014_bib35","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1056\/NEJMe1209381","article-title":"Tiotropium for asthma--promise and caution","volume":"367","author":"Bel","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"Suppl","key":"10.1016\/j.rmed.2018.08.014_bib36","first-page":"59","article-title":"The fixed-dose combination of tiotropium + olodaterol has a rapid onset of action in patients with COPD","volume":"46","author":"Ferguson","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2018.08.014_bib37","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/14740338.2016.1199682","article-title":"Tiotropium for the treatment of asthma: a drug safety evaluation","volume":"15","author":"Kerstjens","year":"2016","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.rmed.2018.08.014_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.rmed.2016.07.001","article-title":"Safety and tolerability of once-daily tiotropium Respimat\u00ae as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: a pooled safety analysis","volume":"118","author":"Dahl","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","article-title":"The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol","volume":"129","author":"Nelson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2018.08.014_bib40","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1056\/NEJMoa1511190","article-title":"Serious asthma events with budesonide plus formoterol vs. budesonide alone","volume":"375","author":"Peters","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib41","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1056\/NEJMoa1511049","article-title":"Serious asthma events with fluticasone plus salmeterol versus fluticasone alone","volume":"374","author":"Stempel","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"Suppl","key":"10.1016\/j.rmed.2018.08.014_bib42","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.14219\/jada.archive.2007.0358","article-title":"Dry mouth and its effects on the oral health of elderly people","volume":"138","author":"Turner","year":"2007","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.rmed.2018.08.014_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.rmed.2016.06.013","article-title":"Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status","volume":"117","author":"Kerstjens","year":"2016","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib44","first-page":"PA647","article-title":"Once-daily tiotropium Respimat\u00ae add-on therapy improves lung function and asthma control in moderate symptomatic asthma, independent of baseline characteristics","volume":"50","author":"Casale","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2018.08.014_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2017.08.037","article-title":"Tiotropium Respimat add-on is efficacious in symptomatic asthma, independent of T2 phenotype","volume":"6","author":"Casale","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2018.08.014_bib46","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S2213-2600(13)70289-3","article-title":"Effect of rare variants in ADRB2 on risk of severe exacerbations and symptom control during longacting beta agonist treatment in a multiethnic asthma population: a genetic study","volume":"2","author":"Ortega","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib47","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1164\/rccm.201103-0514OC","article-title":"Impact of race on asthma treatment failures in the asthma clinical research network","volume":"184","author":"Wechsler","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib48","doi-asserted-by":"crossref","first-page":"e0124109","DOI":"10.1371\/journal.pone.0124109","article-title":"Long-term once-daily tiotropium Respimat\u00ae is well tolerated and maintains efficacy over 52 weeks in patients with symptomatic asthma in Japan: a randomised, placebo-controlled study","volume":"10","author":"Ohta","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2018.08.014_bib49","first-page":"833","article-title":"Use of inhaled anticholinergic agents in obstructive airway disease","volume":"52","author":"Restrepo","year":"2007","journal-title":"Respir. Care"},{"key":"10.1016\/j.rmed.2018.08.014_bib50","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/thx.2006.059386","article-title":"Arginine-16 beta 2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol","volume":"61","author":"Palmer","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2018.08.014_bib51","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study","volume":"170","author":"Bateman","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib52","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1164\/rccm.200902-0166OC","article-title":"The prevalence of nonadherence in difficult asthma","volume":"180","author":"Gamble","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib53","first-page":"145","article-title":"Development of Respimat\u00ae Soft Mist\u2122 inhaler and its clinical utility in respiratory disorders","volume":"4","author":"Dalby","year":"2011","journal-title":"Med. Devices (Auckl)"},{"key":"10.1016\/j.rmed.2018.08.014_bib54","first-page":"1","article-title":"Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide","volume":"8","author":"Price","year":"2015","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.rmed.2018.08.014_bib55","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jaci.2006.10.043","article-title":"Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations","volume":"119","author":"Gibson","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2018.08.014_bib56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MCP.0000000000000342","article-title":"T2-low asthma: current approach to diagnosis and therapy","volume":"23","author":"Samitas","year":"2017","journal-title":"Curr. Opin. Pulm. Med."},{"key":"10.1016\/j.rmed.2018.08.014_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12962-018-0089-8","article-title":"Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US","volume":"16","author":"Zafari","year":"2018","journal-title":"Cost Eff. Resour. Allocation"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611118302804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611118302804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:42:05Z","timestamp":1760614925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611118302804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":57,"alternative-id":["S0954611118302804"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2018.08.014","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiotropium add-on to inhaled corticosteroids versus addition of long-acting \u03b22-agonists for adults with asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2018.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}